Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome

NCT06414096 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
5
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Colorado, Denver